Acute respiratory distress syndrome (ARDS) is present in >10% of all people admitted to critical care and is associated with severe morbidity and mortality. Despite more than half a century since its ...
In conclusion, the findings of this study provide evidence that glucocorticoid treatment-induced down-regulation of systemic inflammation in ARDS is associated with a significant improvement in ...
The approval is for the treatment of adult patients with SARS-CoV-2-induced acute respiratory distress syndrome or ARDS who are receiving systemic corticosteroids as part of standard care and ...
In a groundbreaking study led by Dr. Ying Chen and her team from Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, researchers have uncovered a novel mechanism behind endothelial ...
PA Media on MSN23m
Doctor defends decision not to give antibiotics to baby before deathBen Condon, who was two months old, died at Bristol Children’s Hospital in April 2015 after developing a respiratory illness.
Hosted on MSN1mon
Healios KK Advances ARDS Treatment ApprovalHealios KK (JP:4593) has released an update. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly ...
The lack of a clear concept challenges the general practitioner's decision-making when a diagnosis or a treatment approach must be selected for a patient with a functional disorder. This calls for ...
other treatments with varying levels of intensity ... IC also showed a higher probability of positive absolute risk differences (ARDs) in abstinence at 3 months vs. QL and QL+ with 99% and 98% ...
About Veru Inc. Veru is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of cardiometabolic diseases, oncology, and ARDS. The Company’s drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results